Literature DB >> 18628725

Outcome of fluocinolone acetonide implant (Retisert) reimplantation for chronic noninfectious posterior uveitis.

Mehran Taban1, Careen Y Lowder, Peter K Kaiser.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18628725     DOI: 10.1097/IAE.0b013e31817d8bf2

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


× No keyword cloud information.
  9 in total

Review 1.  Ocular delivery of proteins and peptides: Challenges and novel formulation approaches.

Authors:  Abhirup Mandal; Dhananjay Pal; Vibhuti Agrahari; Hoang My Trinh; Mary Joseph; Ashim K Mitra
Journal:  Adv Drug Deliv Rev       Date:  2018-01-13       Impact factor: 15.470

2.  Intraocular pharmacokinetics of a crystalline lipid prodrug, octadecyloxyethyl-cyclic-cidofovir, for cytomegalovirus retinitis.

Authors:  Lingyun Cheng; James R Beadle; Ajay Tammewar; Karl Y Hostetler; Carl Hoh; William R Freeman
Journal:  J Ocul Pharmacol Ther       Date:  2011-02-25       Impact factor: 2.671

3.  New Drugs and New Posterior Delivery Methods in CME.

Authors:  João Rafael de Oliveira Dias; Renata Portella Nunes; Raquel Goldhardt
Journal:  Curr Ophthalmol Rep       Date:  2017-04-07

4.  Intravitreal injection versus systematic treatment in patients with uveitis undergoing cataract surgery: a systematic review and meta-analysis.

Authors:  Yun-Hsiu Hsieh; Hong-Jie Jhou; Po-Huang Chen; Yih-Shiou Hwang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-10-22       Impact factor: 3.535

5.  Hydrosilylated porous silicon particles function as an intravitreal drug delivery system for daunorubicin.

Authors:  Kathrin I Hartmann; Alejandra Nieto; Elizabeth C Wu; William R Freeman; Jae Suk Kim; Jay Chhablani; Michael J Sailor; Lingyun Cheng
Journal:  J Ocul Pharmacol Ther       Date:  2013-02-28       Impact factor: 2.671

Review 6.  Ocular delivery of macromolecules.

Authors:  Yoo Chun Kim; Bryce Chiang; Xianggen Wu; Mark R Prausnitz
Journal:  J Control Release       Date:  2014-07-03       Impact factor: 9.776

7.  Long-term follow-up of patients treated with multiple fluocinolone acetonide implants for noninfectious uveitis.

Authors:  Rebekah C Allen; Eric B Suhler; Christina J Flaxel; Zunqiu Chen; Dongseok Choi
Journal:  J Ophthalmic Inflamm Infect       Date:  2012-03-13

8.  A sustained intravitreal drug delivery system with remote real time monitoring capability.

Authors:  Huiyuan Hou; Alejandra Nieto; Akram Belghith; Kaihui Nan; Yangyang Li; William R Freeman; Michael J Sailor; Lingyun Cheng
Journal:  Acta Biomater       Date:  2015-06-15       Impact factor: 8.947

9.  Scleral melt following Retisert intravitreal fluocinolone implant.

Authors:  Ilias Georgalas; Chrysanthi Koutsandrea; Dimitrios Papaconstantinou; Dimitrios Mpouritis; Petros Petrou
Journal:  Drug Des Devel Ther       Date:  2014-11-28       Impact factor: 4.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.